UA85069C2 - Combined medicinal therapy for obesity treatment - Google Patents

Combined medicinal therapy for obesity treatment

Info

Publication number
UA85069C2
UA85069C2 UAA200606741A UAA200606741A UA85069C2 UA 85069 C2 UA85069 C2 UA 85069C2 UA A200606741 A UAA200606741 A UA A200606741A UA A200606741 A UAA200606741 A UA A200606741A UA 85069 C2 UA85069 C2 UA 85069C2
Authority
UA
Ukraine
Prior art keywords
obesity treatment
medicinal therapy
combined medicinal
antidepressant
combined
Prior art date
Application number
UAA200606741A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джон К. Сид
Original Assignee
Теракос, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Теракос, Инк. filed Critical Теракос, Инк.
Publication of UA85069C2 publication Critical patent/UA85069C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Provided are methods of achieving desirable weight loss in an overweight or obese individual by administering at least one anticholinesterase agent and at least one antidepressant. The invention also provides for pharmaceutical compositions and kits for simultaneous delivery of at least one anticholinesterase agent and at least one antidepressant
UAA200606741A 2003-11-19 2004-11-19 Combined medicinal therapy for obesity treatment UA85069C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52361003P 2003-11-19 2003-11-19

Publications (1)

Publication Number Publication Date
UA85069C2 true UA85069C2 (en) 2008-12-25

Family

ID=37674884

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200606741A UA85069C2 (en) 2003-11-19 2004-11-19 Combined medicinal therapy for obesity treatment

Country Status (2)

Country Link
CN (1) CN1905865A (en)
UA (1) UA85069C2 (en)

Also Published As

Publication number Publication date
CN1905865A (en) 2007-01-31

Similar Documents

Publication Publication Date Title
SG148169A1 (en) Combination drug therapy to treat obesity
WO2004110368A3 (en) Combination therapy for the treatment of hypertension
WO2005000217A3 (en) Combination therapy for the treatment of dyslipidemia
SG166775A1 (en) Combinations and modes of administration of therapeutic agents and combination therapy
WO2005120461A3 (en) Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
EP1558220A4 (en) Oral compositions for treatment of diseases
TW200612987A (en) Combination treatment for non-hematologic malignancies
MXPA05012155A (en) Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases.
TW200744642A (en) Novel peptides for use in the treatment of obesity
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
TW200508214A (en) Novel compounds
TW200500355A (en) Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
AU2003301190A1 (en) Administration of capsaicinoids
WO2004009015A3 (en) Combination therapy for the treatment of obesity
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
AU4550801A (en) Herbal composition phy906 and its use in chemotheraphy
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
TW200630105A (en) Herbal composition PHY906 and its use in chemotherapy
MX2010006388A (en) Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists.
TW200738228A (en) Neramexane modified release matrix tablet
TW200611695A (en) Pyrrolopyridine derivatives
WO2006036770A3 (en) Combination therapy for the treatment of obesity
WO2005046593A3 (en) Methods and compositions using thalidomide for the treatment and management of cancers and other diseases.
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists